Documentdetail
ID kaart

oai:pubmedcentral.nih.gov:1007...

Onderwerp
Article
Auteur
Vermunt, L. Sutphen, C. Dicks, E. de Leeuw, D.M. Allegri, R. Berman, S.B. Cash, D.M. Chhatwal, J.P. Cruchaga, C. Day, G. Ewers, M. Farlow, M. Fox, N.C. Ghetti, B. Graff-Radford, N. Hassenstab, J. Jucker, M. Karch, C M. Kuhle, J. Laske, C. Levin, J. Masters, C.L McDade, E. Mori, H. Morris, J.C. Perrin, R.J. Preische, O. Schofield, P.R. Suárez-Calvet, M. Xiong, C. Scheltens, P. Teunissen, C.E. Visser, P.J. Bateman, R.J. Benzinger, T.L.S. Fagan, A.M. Gordon, B.A. Tijms, B.M.
Langue
en
Editor

Cold Spring Harbor Laboratory

Categorie

medrxiv

Jaar

2023

vermelding datum

12-04-2023

Trefwoorden
alzheimer changes disease axonal integrity loss
Metriek

Beschrijving

Brain development and maturation leads to grey matter networks that can be measured using magnetic resonance imaging.

Network integrity is an indicator of information processing capacity which declines in neurodegenerative disorders such as Alzheimer disease (AD).

The biological mechanisms causing this loss of network integrity remain unknown.

Cerebrospinal fluid (CSF) protein biomarkers are available for studying diverse pathological mechanisms in humans and can provide insight into decline.

We investigated the relationships between 10 CSF proteins and network integrity in mutation carriers (N=219) and noncarriers (N=136) of the Dominantly Inherited Alzheimer Network Observational study.

Abnormalities in Aβ, Tau, synaptic (SNAP-25, neurogranin) and neuronal calcium-sensor protein (VILIP-1) preceded grey matter network disruptions by several years, while inflammation related (YKL-40) and axonal injury (NfL) abnormalities co-occurred and correlated with network integrity.

This suggests that axonal loss and inflammation play a role in structural grey matter network changes.

KEY POINTS: Abnormal levels of fluid markers for neuronal damage and inflammatory processes in CSF are associated with grey matter network disruptions.

The strongest association was with NfL, suggesting that axonal loss may contribute to disrupted network organization as observed in AD.

Tracking biomarker trajectories over the disease course, changes in CSF biomarkers generally precede changes in brain networks by several years.

Vermunt, L.,Sutphen, C.,Dicks, E.,de Leeuw, D.M.,Allegri, R.,Berman, S.B.,Cash, D.M.,Chhatwal, J.P.,Cruchaga, C.,Day, G.,Ewers, M.,Farlow, M.,Fox, N.C.,Ghetti, B.,Graff-Radford, N.,Hassenstab, J.,Jucker, M.,Karch, C M.,Kuhle, J.,Laske, C.,Levin, J.,Masters, C.L,McDade, E.,Mori, H.,Morris, J.C.,Perrin, R.J.,Preische, O.,Schofield, P.R.,Suárez-Calvet, M.,Xiong, C.,Scheltens, P.,Teunissen, C.E.,Visser, P.J.,Bateman, R.J.,Benzinger, T.L.S.,Fagan, A.M.,Gordon, B.A.,Tijms, B.M., 2023, Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease , Cold Spring Harbor Laboratory

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw